North America breast lesion localization methods market is expected to reach USD 616.57 million by 2025 from USD 248.87 million in 2017, at a CAGR of 12.1% in the forecast period 2018 to 2025.

The major factors driving the market are rising prevalence of breast cancer and increasing breast cancer surgeries. The breast lesion localization methods market in the North America region is leading in U.S.

The key market players for North America breast lesion localization methods market are listed below;

C. R. Bard, Inc.
CP Medical, Inc.
Cianna Medical
Cook Group
STERYLAB S.r.l.
SOMATEX Medical Technologies GmbH
Elucent Medical
ARGON MEDICAL
Tsunami S.r.l.
M.D.L. srl
Biomedical Srl


The market is further segmented into;
Type
Biopsy techniques
End-user

The North America breast lesion localization methods market is segmented on the basis of type, biopsy technique and end users. The report provides data for 2016 to 2025, 2017 being the current year while 2018 to 2025 is the forecast period for the report.
The North America breast lesion localization market is segmented based on type into wire localization, radioisotope localization, magnetic tracers and others. North America breast lesion localization market is dominated by wire localization with 44.8% market share in 2018, growing at a CAGR of 11.9% in the forecast period. The radioisotope localization is further sub segmented into radioactive seed localization and radio occult lesion localization.
The North America breast lesion localization market is segmented on the basis of biopsy techniques into fine needle aspiration biopsy, core needle biopsy, surgical biopsy, vacuum-assisted breast biopsy and others. North America breast lesion localization market is dominated by fine needle aspiration biopsy with 44.8% market share in 2018, growing at a CAGR of 12.3% in the forecast period. The surgical biopsy is further sub segmented into incisional biopsy and excisional biopsy.
The North America breast lesion localization market is segmented on the basis of end user into diagnostic centers, hospitals, oncology clinics and ambulatory surgical centers. North America breast lesion localization market is dominated by hospitals with 44.8% market share in 2018, growing at a CAGR of 12.7% in the forecast period.

Based on geography, the North America breast lesion localization market is segmented into geographical regions, such as,
U.S.,
Canada
Mexico

Covered in this report
The report covers the present scenario and the growth prospects of the North America breast lesion localization market for 2018-2025. To calculate the market size, the report considers the revenue generated from the sales of the web conferencing and unified communication and collaboration (UC&C) and video conferencing, secondary resources and doing in-depth company share analysis of major 10 players in the market.
You can request one free hour of our analyst?s time when you purchase this market report. Details are provided within the report.